GulfBase GCC Cap Indices
IndexLevelChg%
Large Cap3,912 -0.22
Med Cap3,902 0.08
Small Cap5,065 -0.07
Micro Cap8,584 0.50

Research Reports

Quick Links

Most Viewed News

Most Viewed Companies

Ticker Price Volume
QNBK 143.8 312,074
SABIC 95.98 4,534,377
GFH 0.62 131,131
DU 5.58 788,634
ALMARAI 73.08 135,963
RIBL 10.33 260,208
EEC 20.57 1,278,229

Recommendations

GCC Saudi Arabia UAE Kuwait Bahrain Muscat Qatar

Al Rajhi Bank share rated “Neutral” by Al Jazira Capital

Al Rajhi Bank target price was reported by Al Jazira Capital at SAR 70.30 with a potential upside of 9.1% from its market price of SAR 64.46 at report date, 18 April, 2017.

Yamamah Saudi Cement share rated “Neutral” by NCB Capital

Yamamah Saudi Cement target price was reported by NCB Capital at SAR 20.30 with a potential upside of 12.8% from its market price of SAR 18.00 at report date, 18 April, 2017.

ZAIN KSA share rated “Neutral” by AlBilad Investment

ZAIN KSA target price was reported by AlBilad Investment at SAR 9.60 with a potential downside of 5% from its market price of SAR 10.10 at report date, 17 April, 2017.

Savola share rated “Overweight” by Arbah Capital

Savola fair market value was reported by Arbah Capital at SAR 47.00 with a potential upside of 11.5% from its market price of SAR 42.17 at report date, 13 April, 2017.

Herfy Food Services share rated “Overweight” by Arbah Capital

Herfy Food Services fair market value was reported by Arbah Capital at SAR 89.50 with a potential upside of 10.5% from its market price of SAR 81.03 at report date, 13 April, 2017.

Dallah Healthcare share rated “Neutral” by Arbah Capital

Dallah Healthcare fair market value was reported by Arbah Capital at SAR 110.00, with a potential upside of 9.5% from its market price of SAR 100.45 at report date, 13 April, 2017.

Al Mouwasat Medical Services share rated “Neutral” by Arbah Capital

Al Mouwasat Medical Services fair market value was reported by Arbah Capital at SAR 145.00 with a potential downside of 4.6% from its market price of SAR 151.93 at report date, 13 April, 2017.

National Medical Care share rated “Overweight” by Arbah Capital

National Medical Care fair market value was reported by Arbah Capital at SAR 62.00, with a potential upside of 14.4% from its market price of SAR 54.20 at report date, 13 April, 2017.

Al Hammadi Development & Investment share rated “Neutral” by Arbah Capital

Al Hammadi Development & Investment fair market value was reported by Arbah Capital at SAR 45.50, with a potential upside of 4.8% from its market price of SAR 43.42 at report date, 13 April, 2017.

Zain KSA share rated “Neutral” by Al Rajhi Capital

Zain KSA target price was reported by Al Rajhi Capital at SAR 9.50 with a potential downside of 5.5% from its market price of SAR 10.05 at report date, 13 April, 2017.

Zain KSA share recommended “Buy” by Riyad Capital

Zain KSA target price was reported by Riyad Capital at SAR 13.00 with a potential upside of 42.1% from its market price of SAR 9.15 at report date, 12 April, 2017.

SABIC share rated “Neutral” by Al Rajhi Capital

SABIC target price was reported by Al Rajhi Capital at SAR 97.00 with a potential downside of 0.7% from its market price of SAR 97.73 at report date, 07 March, 2017.

Yanbu National Petrochemicals share rated “Neutral” by Al Rajhi Capital

Yanbu National Petrochemicals target price was reported by Al Rajhi Capital at SAR 58.00 with a potential upside of 0.7% from its market price of SAR 57.58 at report date, 07 March, 2017.

Saudi Arabian Fertilizers share rated “Neutral” by Al Rajhi Capital

Saudi Arabian Fertilizers target price was reported by Al Rajhi Capital at SAR 62.00, with a potential downside of 12.7% from its market price of SAR 71.00 at report date, 07 March, 2017.

Advanced Petrochemical share rated “Neutral” by Al Rajhi Capital

Advanced Petrochemical target price was reported by Al Rajhi Capital at SAR 46.00, with a potential downside of 2.1% from its market price of SAR 47.01 at report date, 07 March, 2017.

Saudi International Petrochemical share rated “Overweight” by Al Rajhi Capital

Saudi International Petrochemical target price was reported by Al Rajhi Capital at SAR 20.40, with a potential upside of 12.6% from its market price of SAR 18.11 at report date, 07 March, 2017.

Al Mouwasat Medical Services share rated “Neutral” by Arbah Capital

Al Mouwasat Medical Services fair market value was reported by Arbah Capital at SAR 131.10 with a potential downside of 10% from its market price of SAR 145.61 at report date, 22 February, 2017.

Al Hammadi Development & Investment share rated “Neutral” by Arbah Capital

Al Hammadi Development & Investment fair market value was reported by Arbah Capital at SAR 34.50, with a potential downside of 3.1% from its market price of SAR 35.62 at report date, 22 February, 2017.

National Medical Care share rated “Neutral” by Arbah Capital

National Medical Care fair market value was reported by Arbah Capital at SAR 51.20, with a potential downside of 3.3% from its market price of SAR 52.96 at report date, 22 February, 2017.

Dallah Healthcare share rated “Neutral” by Arbah Capital

Dallah Healthcare target price was reported by Arbah Capital at SAR 103.50, with a potential upside of 5.1% from its market price of SAR 98.50 at report date, 22 February, 2017.

GulfBase GCC Index
Search By
  • Company Symbol
  • Company Name
  • Mutual Fund Name
  • News Content
Send this page to a friend

Poll

Looking ahead, what change you are more likely to make in investing in your domestic stock market?